We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Oramed Pharmaceuticals Inc | NASDAQ:ORMP | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.03 | 1.19% | 2.56 | 2.50 | 2.63 | 2.6001 | 2.535 | 2.54 | 101,947 | 01:00:00 |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16 OF THE
SECURITIES EXCHANGE ACT OF 1934
July 18, 2013
Barclays Bank PLC
(Name of Registrant)
1 Churchill Place
London E14 5HP
England
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:
Form 20-F x Form 40-F o
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): o
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): o
THIS REPORT ON FORM 6-K SHALL BE DEEMED TO BE INCORPORATED BY REFERENCE IN THE REGISTRATION STATEMENT OF BARCLAYS BANK PLC ON FORM F-3 (NO. 333-169119) AND TO BE A PART THEREOF FROM THE DATE ON WHICH THIS REPORT IS FURNISHED, TO THE EXTENT NOT SUPERSEDED BY DOCUMENTS OR REPORTS SUBSEQUENTLY FILED OR FURNISHED.
Exhibits are filed herewith in connection with the issuance of the following Global Medium-Term Notes, Series A (collectively, the Notes) by Barclays Bank PLC (the Company) on date of this report on Form 6-K, pursuant to the Companys automatic shelf registration statement on Form F-3 (File No. 333- 169119 ):
· $1,000,000 Phoenix Autocallable Notes due August 1, 2014 Linked to the Common Stock of Michael Kors Holdings Limited
· US$160,000 3.00% Fixed Rate Notes due July 18, 2025
Exhibit No. |
|
Description |
5.1 |
|
Opinion of Sullivan & Cromwell LLP, U.S. counsel to the Company, with respect to the validity of the Notes under New York law. |
5.2 |
|
Opinion of Sullivan & Cromwell LLP, English counsel to the Company with respect to the Notes, as to certain matters under English law. |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, each of the registrants has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorised.
|
|
|
BARCLAYS BANK PLC |
|
|
|
|
(Registrant) |
|
|
|
|
||
|
|
|
||
Date: July 18, 2013 |
|
By: |
/s/ Johnny Wu |
|
|
|
|
Name: |
Johnny Wu |
|
|
|
Title: |
Managing Director |
1 Year Oramed Pharmaceuticals Chart |
1 Month Oramed Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions